• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    PetMed Express, Inc. and Dutch Announce Partnership to Provide Accessible Telehealth Services for Pets

    5/7/25 9:08:06 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $PETS alert in real time by email

    DELRAY BEACH, Fla. and OAKLAND, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., parent company of PetMeds and PetCareRx (NASDAQ:PETS), today announced a new strategic partnership with virtual veterinary care provider Dutch. The collaboration marks PetMeds' latest move to expand its provider ecosystem with affordable, accessible pet healthcare options. The new partnership will enable pet parents to leverage Dutch's convenient technology and veterinary team to secure prescriptions for PetMeds' broad selection of medications in a timely manner.

    "This partnership expands the accessibility of pet telemedicine, which can help fill gaps in care, as the nationwide vet shortage has left more than 129 million Americans without easy access to pet care," said Joe Spector, Founder and CEO of Dutch. "Through this collaboration, we are looking forward to reaching a broader audience of pet parents in need of care and medications."

    "At PetMeds, we believe the veterinarian is—and will always be—at the center of a pet's healthcare journey," said Sandra Campos, President and CEO of PetMeds. "By integrating Dutch's virtual care platform into our growing pet health ecosystem, we're expanding access to timely, professional care, particularly when in-person visits aren't possible due to geography, timing or cost. This partnership is designed to support the 200 veterinarians who are employed by Dutch and aid continuity of care while helping ensure pet parents receive expert guidance, whenever and wherever it's needed."

    Under the partnership, pet parents will be able to sign up for a monthly Dutch membership and be connected virtually with veterinarians for 24/7 appointments in 34 states. Since launched, Dutch has completed almost 700,000 visits and offers treatment options for over 150 conditions, including flea and tick medication and treatments for allergies and joint pain.

    Consumer awareness and adoption of veterinary telehealth options are accelerating as pet parents look for more affordable, accessible ways to keep their beloved pets healthy and happy. Dutch's recently released 2025 State of Veterinary Care Report found that 129 million Americans, or roughly 38% of the population, live in vet-care "deserts"—underscoring the significant need for more accessible pet care options.

    About PetMed Express, Inc.

    Founded in 1996, PetMeds is a leader in the consumer pet healthcare sector. As a national online retailer with expert pharmacists and licenses across fifty states, PetMeds.com and PetCareRx.com deliver top branded pharmaceuticals, generics, compounded prescription medications and OTC supplements and vitamins that help pets live longer, healthier lives. The Company strives to offer unparalleled value and convenience that enhance wellness and longevity for dogs, cats, and horses. PetMeds and PetCareRx provide essential pet health offerings through their websites, www.PetMeds.com and www.PetCareRx.com.

    About Dutch

    Launched in July 2021, Dutch is the first and only veterinary telehealth company connecting licensed, independent veterinarians directly with pets and their parents nationwide. At its inception, Dutch primarily addressed common chronic ailments, such as anxiety and allergies, but has grown to treat over 150 conditions and serve over 40,000 customers. In 2022, Dutch introduced Rx services, which allow the company's licensed veterinarians to prescribe and ship OTC and prescription medications to patients in 34 states. Dutch memberships, excluding insurance, begin at just $15/month, and include unlimited access to virtual veterinary care through video and chat models. In a country experiencing a critical vet shortage of just one veterinarian for every 6,000 pet households, Dutch is creating a more accessible means of dependable, quality vet care that can address the modern pet parents' needs in a timely manner and at a fraction of the cost.

    Media Contacts

    For PetMeds:

    Danielle Poggi

    [email protected]

    Reed Anderson

    [email protected]

    For Dutch:

    Melissa Stavenhagen

    [email protected]



    Primary Logo

    Get the next $PETS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PETS

    DatePrice TargetRatingAnalyst
    5/25/2023$20.00Buy
    Lake Street
    1/25/2022$25.00 → $21.00Underweight
    Morgan Stanley
    1/20/2022$32.00Neutral → Buy
    Sidoti
    11/18/2021$25.00Underweight
    Morgan Stanley
    10/1/2021$28.00Hold
    Jefferies
    8/5/2021$22.00Underperform
    Credit Suisse
    More analyst ratings

    $PETS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited

    DELRAY BEACH, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company" or "PetMeds"), today confirmed that it has received an unsolicited and non-binding acquisition proposal from SilverCape Investments Limited, a Singapore-based investment firm, to acquire all of the outstanding shares of the Company for $4 per share in cash, subject to various conditions such as due diligence and the execution of a mutually acceptable definitive agreement, but not subject to any financing contingency. While PetMeds would typically not publicly comment on privately submitted and non-binding acquisition proposals, SilverCape h

    12/11/25 9:45:00 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them

    DELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company"), today unveiled its new Holiday Collection, a curated selection of health, wellness, and lifestyle products designed for pet parents who want to give purposeful, practical gifts this season. Unlike traditional pet gifts such as toys or beds, PetMeds' giftable assortment focuses on products that improve pets' everyday health, comfort, safety, and happiness, making them ideal for the pet owner who has everything. "With more pet parents treating their furry friends like true members of the family, holiday gifting has shifted toward smart, we

    12/10/25 8:00:00 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PetMeds Extends Existing Shareholder Rights Plan

    DELRAY BEACH, Fla., Nov. 26, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company"), today announced that its Board of Directors (the "Board") has unanimously approved an amendment to the Company's existing shareholder rights plan (the "Rights Plan"), pursuant to which the expiration date of the Rights was extended for one year from the close of business on December 2, 2025 until the close of business on December 2, 2026. All other terms and conditions of the Rights Plan remain unchanged. The Board adopted the Rights Plan to protect the investment of shareholders during a period in which it believes shares of the Company

    11/26/25 4:05:00 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $PETS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on PetMed Express with a new price target

    Lake Street initiated coverage of PetMed Express with a rating of Buy and set a new price target of $20.00

    5/25/23 9:17:49 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Morgan Stanley reiterated coverage on PetMed Express with a new price target

    Morgan Stanley reiterated coverage of PetMed Express with a rating of Underweight and set a new price target of $21.00 from $25.00 previously

    1/25/22 10:17:17 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PetMed Express upgraded by Sidoti with a new price target

    Sidoti upgraded PetMed Express from Neutral to Buy and set a new price target of $32.00

    1/20/22 9:13:56 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $PETS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fulgoni Gian was granted 33,846 shares, increasing direct ownership by 27% to 158,356 units (SEC Form 4)

    4 - PETMED EXPRESS INC (0001040130) (Issuer)

    11/14/25 5:26:21 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CAO and Interim CFO Krulik Douglas was granted 20,000 shares, increasing direct ownership by 40% to 70,000 units (SEC Form 4)

    4 - PETMED EXPRESS INC (0001040130) (Issuer)

    11/3/25 4:08:40 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Lacamp James was granted 34,866 shares (SEC Form 4)

    4 - PETMED EXPRESS INC (0001040130) (Issuer)

    11/3/25 4:07:32 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $PETS
    SEC Filings

    View All

    SEC Form DEF 14A filed by PetMed Express Inc.

    DEF 14A - PETMED EXPRESS INC (0001040130) (Filer)

    12/10/25 4:27:44 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PetMed Express Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    8-K - PETMED EXPRESS INC (0001040130) (Filer)

    12/9/25 4:18:11 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Amendment: SEC Form 8-A12B/A filed by PetMed Express Inc.

    8-A12B/A - PETMED EXPRESS INC (0001040130) (Filer)

    11/26/25 4:12:12 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $PETS
    Leadership Updates

    Live Leadership Updates

    View All

    PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair

    Seasoned corporate director brings extensive expertise in audit, accounting, and internal controls Fourth independent director to join the board since 2024 DELRAY BEACH, Fla., Oct. 20, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company"), today announced the appointment, effective immediately, of James LaCamp to the Company's Board of Directors (the "Board"), and effective October 30, Mr. LaCamp will become Chair of the Audit Committee of the Board. Mr. LaCamp also qualifies as an "audit committee financial expert" within the meaning of the SEC's rules and regulations. Mr. LaCamp brings close to two decades of experie

    10/20/25 8:30:00 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PetMeds Partners with myBalto Foundation to Raise Nearly $45,000 to Alleviate Financial Stress Pet Owners Face with Emergency Vet Bills

    DELRAY BEACH, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS) today announced that it partnered with the myBalto Foundation for its recent "Top of the Class" fundraising drive, resulting in nearly $45,000 in donations. myBalto is a leading platform dedicated to empowering veterinary hospitals to support pets with critical veterinary care. Its Foundation offers veterinary hospitals a free Angel Fund, eliminating the administrative burdens of setting up and managing a traditional charity, to help pet parents in need pay for emergency veterinarian costs. "PetMeds is proud to stand alongside organizations like myBalto Foundation that are expanding acces

    7/23/25 8:00:00 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th

    DELRAY BEACH, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- In celebration of National Pet Day, PetMed Express, Inc. (NASDAQ:PETS)—the original consumer pet healthcare company serving dogs, cats, and horses for nearly 30 years—will ring the Nasdaq Opening Bell this Friday, April 11, 2025. This momentous occasion honors the powerful bond between people and their pets and will feature adoptable rescue dogs from Bidawee, one of the nation's oldest no-kill animal welfare organizations. It's a tribute to the joy and unconditional love pets bring into our lives–and a reminder of how many still await families of their own. "Our pets are more than just animals; they are family," said Sandra Campo

    4/11/25 9:00:00 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $PETS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Silvercape Investments Ltd bought $320,170 worth of shares (101,000 units at $3.17), increasing direct ownership by 4% to 2,579,696 units (SEC Form 4)

    4 - PETMED EXPRESS INC (0001040130) (Issuer)

    8/14/25 8:40:29 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Large owner Silvercape Investments Ltd bought $379,422 worth of shares (118,200 units at $3.21), increasing direct ownership by 5% to 2,478,696 units (SEC Form 4)

    4 - PETMED EXPRESS INC (0001040130) (Issuer)

    8/4/25 8:26:23 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Large owner Nina Capital Holdings Inc. bought $87,425 worth of shares (25,000 units at $3.50), increasing direct ownership by 0.98% to 2,575,000 units (SEC Form 4)

    4 - PETMED EXPRESS INC (0001040130) (Issuer)

    7/22/25 4:15:16 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $PETS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PetMed Express Inc.

    SC 13G - PETMED EXPRESS INC (0001040130) (Subject)

    11/14/24 4:02:14 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G filed by PetMed Express Inc.

    SC 13G - PETMED EXPRESS INC (0001040130) (Subject)

    10/10/24 6:26:43 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G/A filed by PetMed Express Inc. (Amendment)

    SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)

    2/13/24 5:12:03 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $PETS
    Financials

    Live finance-specific insights

    View All

    PetMed Express, Inc. Announces Preliminary Fourth Quarter and FY 2025 Results and Filing of Form 12b-25

    DELRAY BEACH, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced preliminary fourth quarter and fiscal year 2025 results and filed Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission. The Company is unable to file its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 within the prescribed time period without unreasonable effort or expense. The Company expects to file its Annual Report on Form 10-K with the Securities and Exchange Commission as soon as practicable, and no later than July 1, 2025, in accordance with Rule 12b-25. Preliminary Fourth Quarter

    6/16/25 8:30:00 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call

    DELRAY BEACH, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced it is delaying the release of the Company's fourth quarter and fiscal year 2025 earnings release and subsequent conference call, which had been scheduled for June 10, 2025, because the Company requires additional time to complete the year-end audit process. The Company anticipates that it will issue the earnings release, hold the related conference call, and file its Annual Report on Form 10-K as soon as possible, but no later than June 16, 2025. About PetMed Express, Inc. Founded in 1996, PetMeds is a leader in pioneering the digital pet p

    6/10/25 4:05:00 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call

    DELRAY BEACH, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Tuesday, June 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fourth quarter and full fiscal year ended March 31, 2025. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Tuesday, June 10, 2025Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562We

    5/27/25 4:05:00 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples